prednisone has been researched along with vindesine in 144 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (22.92) | 18.7374 |
| 1990's | 27 (18.75) | 18.2507 |
| 2000's | 45 (31.25) | 29.6817 |
| 2010's | 31 (21.53) | 24.3611 |
| 2020's | 8 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U | 2 |
| Beardsley, GP; Buchanan, G; Hvizdale, E; Krischer, J; Link, M; Maybee, D; Mehta, P; Nitschke, R; Ragab, A; Vats, T | 1 |
| Kimura, F; Mizukami, H; Motoyoshi, K; Nagata, N; Ohtsuki, T; Takagi, S; Takemura, Y; Yamamoto, K | 1 |
| Bancillon, A; Baruchel, A; Bergeron, C; Leblanc, T; Lejars, O; Lepage, E; Leverger, G; Perel, Y; Schaison, G; Sommelet, D | 1 |
| Oguro, M; Sakai, C; Takagi, T | 1 |
| Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J | 1 |
| Diedrich, H; Freund, M; Ganser, A; Gramatzki, M; Haas, R; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Kuse, R | 1 |
| De Boben, M; Diedrich, H; Freund, M; Ganser, A; Heil, G; Henke, M; Heyll, A; Hiddemann, W; Knauf, U; Koch, P | 1 |
| Bruntsch, U; Eschenbach, I; Gropp, C; Köppler, H; Lötzke, E; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, EU; Zeller, W | 1 |
| Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K | 1 |
| Koziner, B; Zori Comba, A | 1 |
| Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD | 1 |
| Bukowski, RM; Montie, JE; Smith, GW | 1 |
| Straus, DJ | 1 |
| Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ | 1 |
| Kosaka, M; Matsumoto, N; Okagawa, K; Saito, S; Yoshimoto, K | 1 |
| Antman, KH; Ryan, LM; Siegel, RD | 1 |
| Allan, NC; Dawson, AA; Leonard, RC; Lucraft, HH; McGillivray, JB; Parker, AC; Prescott, RJ; Proctor, SJ | 1 |
| Fujimoto, T; Koizumi, S; Mimaya, J; Ninomiya, T; Takeda, T; Utsumi, J; Yanai, M; Yatabe, M | 1 |
| Abel, U; Fritze, D; Heim, ME; Ho, AD; Mebes, W | 1 |
| Bott, SJ; Prince-Fiocco, MA; Stewart, FM | 1 |
| Duhamel, G; Gorin, NC; Laporte, JP; Lemoine, F; Najman, A | 1 |
| Jehn, U; Mezger, J | 2 |
| Monasch, E; Pegels, HG; van der Lelie, H; von dem Borne, AE | 1 |
| Casara, D; Chiarion Sileni, V; De Besi, P; Fiorentino, MV; Frizzarin, M; Paccagnella, A; Salvagno, L | 1 |
| Hellriegel, KP | 1 |
| Clarkson, BD; Koziner, B; Lee, BJ; Myers, J; Straus, DJ | 1 |
| Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ | 1 |
| Dibar, E; Eppinger-Helft, M; Garay, G; Kvicala, R; Milone, J; Montres Varela, D; Pavlovsky, S; Sackmann Muriel, F | 1 |
| Gassel, WD; Gropp, C; Havemann, K | 1 |
| Denning, B; Fontana, JA; Knost, JA; Raich, PC; Rogers, JS; Subramanian, VP; Walker, BK | 1 |
| Ranft, K | 1 |
| Fassas, A; Kartalis, G; Klearchou, N; Mantalenakis, S; Sinacos, Z; Tsatalas, K | 1 |
| Halie, MR; Houwen, B; Marrink, J; Nieweg, HO; Ockhuizen, T; van Dobbenburgh, OA | 1 |
| Halie, MR; Houwen, B; Marrink, J; Nieweg, HO; Ockhuizen, T; Piersma, H; Van Dobbenburgh, OA | 1 |
| Halie, MR; Houwen, B; Jurjens, H; Marrink, J; Nieweg, HO; Van Dobbenburgh, OA | 1 |
| Alexanian, R; Bodey, GP; Yap, BS | 1 |
| Klopovich, P; Mehta, P; Smith, SD; Trueworthy, RC; Vats, TS | 1 |
| de Vassal, F; Delgado, M; Gil-Delgado, MA; Goutner, A; Machover, D; Mathé, G; Misset, JL | 1 |
| Houwen, B; Marrink, J; Nieweg, HO; Ockhuizen, T | 1 |
| Alatriste, S; Avilés, A; Delgado, S; Díaz-Maqueo, JC; Nambo, MJ | 1 |
| Kozielski, J; Rauer, R; Spychałowicz, W; Ziora, D | 1 |
| Avanzini, P; Cavanna, L; Di Renzo, N; Federico, M; Gobbi, PG; Grignani, G; Iannitto, E; Narni, F; Partesotti, G; Pieresca, C | 1 |
| Bartl, R; Beckert, B; Bock, S; Gieseler, F; Gullis, E; Nerl, C; Nüssler, V; Pelka-Fleischer, R; Petrides, PE; Zwierzina, H | 1 |
| Benboubker, L; Colombat, P; Combe, M; Delain, M; Goupille, P; Lamagnère, JP; Linassier, C; Luthier, F; Petitdidier, C; Reisenleiter, M | 1 |
| Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N | 1 |
| Birkmann, J; Eschenbach, I; Gropp, C; Holle, R; Köppler, H; Oehl, S; Pfab, R; Pflüger, KH; Steinhauer, UE; Zeller, W | 1 |
| Briere, J; d'Agay, MF; Diebold, J; Fillet, G; Gaulard, P; Haioun, C; Hermine, O; Lavignac, C; Lepage, E; Marolleau, JP; Reyas, F; Salles, G | 1 |
| Audhuy, B; Blanc, M; Brière, J; Coiffier, B; Diviné, M; Dupriez, B; Herbrecht, R; Lederlin, P; Lepage, E; Mineur, P; Pautier, P; Reyes, F; Tilly, H | 1 |
| Audouin, J; Bernadou, A; Chauvenet, L; Ciaudo, M; Favier, R; Horellou, MH; Rossert, J; Samama, M | 1 |
| Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H | 1 |
| Araki, K; Arima, N; Chiyoda, S; Hosokawa, T; Ikeda, S; Kawano, F; Kikuchi, H; Kinoshita, KI; Kohno, H; Matsuzaki, H; Miyoshi, I; Momita, S; Nishimura, H; Taguchi, H; Takahashi, H; Takatsuki, K; Tamura, K; Tomonaga, M; Tsuda, H; Uozumi, K; Yamada, O | 1 |
| Alberto, P; Anchisi, S; Dietrich, PY; Laurencet, FM; Mermillod, B; Zulian, GB | 1 |
| Aguiló, J; García, F; Gómez, A; Grau, E; Ibáñez, JL; Mirabet, MD; Pastor, E; Perella, M | 1 |
| Brice, P; Cazals, D; Deconinck, E; Doyen, C; Gisselbrecht, C; Hamelsand, J; Molina, T; Moulonguet, I; Mounier, N; Neidhart-Berard, AM; Remenieras, L; Verola, O | 1 |
| Bienvenu, J; Charlot, C; Coiffier, B; Ribeiro, P; Rigal, D; Roy, P; Salles, G; Warzocha, K | 1 |
| Bleuse, JP; Block, S; Bonneterre, J; Bonneterre, ME; Carlier, D; Darloy, F; Fournier, C; Huc, P | 1 |
| Biron, P; Bordessoule, D; Bosly, A; Brière, J; Coiffier, B; Dupriez, B; Herbrecht, R; Lederlin, P; Mounier, N; Nouvel, C; Sebban, C; Tilly, H | 1 |
| Bouabdallah, R; Cole, BF; Gisselbrecht, C; Haioun, C; Lepage, E; Marit, G; Morel, P; Mounier, N; Ravoet, C; Reyes, F; Salles, G; Sebban, C | 1 |
| Delsol, G; Farcet, JP; Gaulard, P; Martin-Garcia, N; Mempel, M; Rigal-Huguet, F; Suarez, F; Wlodarska, I | 1 |
| Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP | 1 |
| Cazals-Hatem, D; Chevret, S; Clauvel, JP; Dubreuil, ML; Gerard, L; Levy, Y; Matheron, S; Oksenhendler, E | 1 |
| Baumelou, E; Brousse, C; Morel, P | 1 |
| André, M; Berger, F; Bosly, A; Brière, J; Cazals-Hatem, D; Copin, MC; Diebold, J; Divine, M; Gaulard, P; Kerneis, Y; Mounier, N; Quesnel, B | 1 |
| Araki, K; Fukuda, H; Hanada, S; Hotta, T; Ikeda, S; Kawano, F; Kozuru, M; Niimi, M; Sano, M; Shimoyama, M; Takatsuki, K; Tara, M; Tobinai, K; Tomonaga, M; Utsunomiya, A; Yamada, Y | 1 |
| Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C | 1 |
| Beaujean, F; Belhadj, K; Gaulard, PH; Gisselbrecht, CH; Haioun, C; Lepage, E; Marolleau, JP; Morel, P; Mounier, N; Quesnel, B; Reyes, F; Rieux, C; Simon, D | 1 |
| Agbalika, F; Boulanger, E; Daniel, MT; Grollet, L; Maarek, O; Molina, JM; Oksenhendler, E; Sigaux, F | 1 |
| Bordessoule, D; Bosly, A; Coiffier, B; Deconninck, E; Divine, M; Dupriez, B; Fillet, G; Gaulard, P; Gisselbrecht, C; Herbrecht, R; Lepage, E; Nouvel, C; Tilly, H | 1 |
| Charlotte, F; Godeau, P; Leblond, V; Piette, JC; Sbaï, A; Wechsler, B | 1 |
| Coiffier, B; Fillet, G; Gabarre, J; Gisselbrecht, C; Guilmin, F; Hermine, O; Lederlin, P; Lepage, E; Molina, T; Quesnel, B; Reyes, F; Tilly, H | 1 |
| Corbacioglu, S; Eber, S; Gungor, T; Hummerjohann, J; Niggli, F | 1 |
| Attal, M; Blanc, M; Bosly, A; Coiffier, B; Fillet, G; Gisselbrecht, C; Guettier, C; Herbrecht, R; Lepage, E; Molina, TJ; Reyes, F; Tilly, H | 1 |
| André, M; Bosly, A; Brice, P; Coiffier, B; Gaulard, P; Gisselbrecht, C; Haioun, C; Henry-Amar, M; Leleu, X; Morel, P; Mounier, N; Reyes, F; Sonet, A; Tilly, H | 1 |
| Bilsland, D; Dawn, G; Jackson, R; Morrison, A; Morton, R | 1 |
| Berthou, C; Colombat, P; Deconinck, E; Delwail, V; Foussard, C; Gaillard, F; Gressin, R; Harousseau, JL; Lucas, V; Milpied, N | 1 |
| Chen, XQ; Guan, ZZ; He, YJ; Huang, HQ; Jiang, WQ; Li, YH; Lin, TY; Liu, DG; Su, YS; Sun, XF; Xia, Y; Xia, ZJ; Zhang, L; Zhen, ZJ; Zhou, ZM | 1 |
| Berthou, C; Casassus, P; Colombat, P; Deconinck, E; Delwail, V; Desablens, B; Foussard, C; Ghandour, C; Gressin, R; Lamy, T; Mahé, B; Maisonneuve, H; Pignon, B; Rachieru, P; Rousselet, MC | 1 |
| Bourgain, C; De Paepe, P; Serreyn, R; Van den Broecke, R; Van Renterghem, N | 1 |
| Bosly, A; Brice, P; Coiffier, B; Ferme, C; Ganem, G; Laurent, G; Lederlin, P; Lepage, E; Molina, TJ; Morel, P; Reyes, F; Tilly, H | 1 |
| Armitage, JO | 1 |
| Ghesquieres, H | 1 |
| Coiffier, B; Reyes, F | 1 |
| Tanvetyanon, T | 1 |
| Hinkelbein, W; Hoecht, S | 1 |
| Adli, M; Kalender, ME; Sevinc, A | 1 |
| Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U | 1 |
| Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F | 1 |
| Kunihiko, M; Mariko, Y; Shinichiro, O; Yasuo, I; Yusuke, T; Yutaka, H | 1 |
| Handa, H; Irisawa, H; Komatsumoto, S; Matsushima, T; Murakami, H; Nojima, Y; Tsukamoto, N | 1 |
| Bergerat, JP; Caillard, S; Chenard, MP; Ellero, B; Epailly, E; Fohrer, C; Herbrecht, R; Kessler, R; Koumarianou, A; Lioure, B; Lutun, P; Maloisel, F; Meyer, C; Moulin, B; Natarajan-Ame, S; Woehl-Jaeglé, ML; Wolf, P | 1 |
| Meng, H; Qian, W; Shao, K; Yang, C; Yang, X; Ye, X; Zhou, Y | 1 |
| Berneman, Z; Bosly, A; Bron, D; Dauwe, M; De Bock, R; Ferrant, A; Kaufman, L; Van Hoof, A; Verhoef, G | 1 |
| Brière, J; Copin, MC; Ferme, C; Gaulard, P; Gisselbrecht, C; Haioun, C; Hermine, O; Lederlin, P; Morel, P; Mounier, N; Salles, G; Theate, I; Tilly, H | 1 |
| Diehl, V; Evens, AM; Hutchings, M | 1 |
| Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D | 1 |
| Fujigaki, H; Hoshi, M; Ito, H; Ohtaki, H; Ohyama, M; Saito, K; Seishima, M; Takahashi, T; Takemura, M; Tanaka, R; Tomita, E | 1 |
| Coiffier, B; Emile, JF; Fermé, C; Gabarre, J; Gisselbrecht, C; Haioun, C; Herbrecht, R; Morchhauser, F; Mounier, N; Ranta, D; Récher, C; Tilly, H | 1 |
| Adibi, A; Azhir, A; Reisi, N; Taheri, D | 1 |
| Cardona, AF; Lawrence, A; Martí-Carvajal, AJ | 1 |
| Kuruvilla, J | 1 |
| Aarden, L; Baars, JW; Beijnen, JH; Huitema, AD; Tran, L | 1 |
| Bosly, A; Brière, J; Coiffier, B; Gisselbrecht, C; Molina, T; Morel, P; Mounier, N; Munck, JN; Quesnel, B; Ranta, D; Reyes, F; Thyss, A; Tilly, H | 1 |
| Bardet, S; Berriolo-Riedinger, A; Bologna, S; Brière, J; Casasnovas, RO; Coiffier, B; Haioun, C; Jais, JP; Julian, A; Meignan, M; Morschhauser, F; Thieblemont, C; Vera, P | 1 |
| Anglaret, B; Belhadj, K; Brechignac, S; Casasnovas, O; Ferme, C; Feugier, P; Fitoussi, O; Gabarre, J; Ghesquieres, H; Gisselbrecht, C; Haioun, C; Herbrecht, R; Janvier, M; Morschhauser, F; Mounier, N; Parrens, M; Salles, G; Tilly, H; Van Den Neste, E; Ysebaert, L | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Baldini, L; Bellei, M; Bordonaro, R; Chisesi, T; Federico, M; Gobbi, P; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Merli, F; Montanini, A; Pavone, V; Pesce, EA; Stelitano, C; Vitolo, U | 1 |
| Vose, JM | 1 |
| Bologna, S; Bonnet, C; Bosly, A; Canioni, D; Casasnovas, O; Coiffier, B; Corront, B; Fermé, C; Fruchart, C; Gabarre, J; Ghesquières, H; Haioun, C; Jais, JP; Janvier, M; Jardin, F; Laurent, G; Molina, TJ; Morschhauser, F; Récher, C; Salles, G; Thiéblemont, C; Tilly, H | 1 |
| Habermann, TM | 1 |
| Bastit-Barrau, D; Bohbot, A; Bologna, S; Bourin, P; Fermé, C; Fitoussi, O; Fornecker, L; Haioun, C; Hequet, O; Isebaert, L; Lapierre, V; Lefrère, F; Mathieu-Nafissi, S; Micléa, JM; Mounier, N; Salles, G; Tilly, H | 1 |
| Chen, J; Wang, H; Wang, R; Xu, Y; Zhang, H | 1 |
| Akiyoshi, K; Hamaguchi, T; Hosokawa, A; Iwasa, S; Kato, K; Nakajima, TE; Nishitani, H; Ogawa, K; Shimada, Y; Sugiyama, T; Ueno, T; Yamada, Y | 1 |
| Anglaret, B; Bologna, S; Bonnet, C; Bordessoule, D; Brière, J; Casasnovas, O; Christian, B; Coiffier, B; Connerotte, T; Delarue, R; Fabiani, B; Fermé, C; Fruchart, C; Haioun, C; Ketterer, N; Morschhauser, F; Récher, C; Soussain, C; Thieblemont, C; Tilly, H | 1 |
| Herbrecht, R; Jarfaut, A; Levêque, D; Santucci, R | 1 |
| Baldolli, A; Chuffart, M; Geffray, L; Reman, O; Verneuil, L | 1 |
| Borchmann, P; Engert, A; Monsef, I; Rancea, M; Skoetz, N; Will, A | 1 |
| Ishigaki, T; Kobayashi, M; Kobayashi, S; Ohno, N; Sato, K; Tojo, A; Uchimaru, K; Watanabe, N; Yuji, K | 1 |
| Ben Salah, H; Boudawara, T; Daoud, J; Elloumi, M; Fourati, N; Frikha, M | 1 |
| Bao, L; Chen, H; Huang, XJ; Jiang, B; Jiang, H; Jiang, Q; Liu, DH; Lu, J; Lu, XJ; Wang, J; Xu, LP; Zhu, HH | 1 |
| Yamamoto, K | 1 |
| Fukushima, T | 1 |
| Berger, F; Brière, J; Canioni, D; Casasnovas, O; Coiffier, B; Copie-Bergman, C; Copin, MC; Fabiani, B; Fermé, C; Gaulard, P; Haioun, C; Jais, JP; Jardin, F; Leroy, K; Molina, TJ; Morschauser, F; Mounier, N; Petrella, T; Recher, C; Salles, G; Thieblemont, C; Tilly, H | 1 |
| Advani, R; Constine, LS; Dabaja, BS; Dhakal, S; Flowers, CR; Ha, CS; Hodgson, DC; Hoppe, BS; Mendenhall, NP; Metzger, ML; Plastaras, JP; Roberts, KB; Shapiro, R; Smith, SM; Terezakis, SA; Winkfield, KM; Younes, A | 1 |
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| Cai, HC; Cao, XX; Chen, M; Duan, MH; Han, B; Han, X; Li, J; Wang, SJ; Yang, C; Zhang, W; Zhou, DB; Zhu, TN; Zhuang, JL | 1 |
| Miyahara, M; Ureshino, H | 1 |
| Ishida, T; Ogura, M; Takahashi, T; Tsukasaki, K; Utsunomiya, A | 1 |
| Amorim, S; Bachy, E; Brière, J; Delarue, R; Gaulard, P; Haioun, C; Lamant, L; Laurent, C; Loschi, M; Morel, A; Sibon, D; Sonet, A; Tilly, H; Tournilhac, O | 1 |
| Horwitz, SM; Mehta-Shah, N; Ratner, L | 1 |
| Beeker, A; Berenschot, HW; Bilgin, YM; Böhmer, LH; Brouwer, RE; Chiţu, D; de Jong, D; Doorduijn, JK; Herbers, AHE; Hijmering, N; Hoogendoorn, M; Kersten, MJ; Koene, HR; Lam, KH; Lugtenburg, PJ; Schouten, HC; van der Burg-de Graauw, NC; van Imhoff, GW; Zijlstra, JM | 1 |
| Li, J; Ping, P; Sun, Y; Xu, Y; Yao, C; Yin, H | 1 |
| Al-Quteimat, OM | 1 |
| Amano, M; Imaizumi, Y; Ishida, T; Ishitsuka, K; Ishizawa, K; Ito, S; Iwanaga, M; Nosaka, K; Ohshima, K; Tanaka, J; Tobinai, K; Tokura, Y; Tsukasaki, K; Uchimaru, K; Uike, N; Utsunomiya, A; Watanabe, T | 1 |
| Fan, W; Lei, W; Pan, H; Tong, X; Wang, S; Wu, Y; Xie, S; Yang, C | 1 |
| Abou Dalle, I; Al Chami, F; Bazarbachi, A; Charafeddine, M; El Cheikh, J; El Darsa, H; El Sayed, R; Ibrahim, A; Kort, J | 1 |
| Jin, M; Wang, Z; Zhai, Z; Zhang, K | 1 |
| Iida, S; Inagaki, H; Ishida, T; Ito, A; Iwasaki, H; Kusumoto, S; Masaki, A; Murase, T; Muto, R; Nakano, N; Sakamoto, Y; Takeshita, M; Tashiro, Y; Tokunaga, M; Ueda, R; Utsunomiya, A; Yonekura, K | 1 |
| Wang, W; Wei, C; Zhang, W; Zhang, Y; Zhao, D; Zhou, D | 1 |
| Lin, Q; Lu, Y; Pei, R | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
15 review(s) available for prednisone and vindesine
| Article | Year |
|---|---|
[Rescue treatment in Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
A clinical, molecular and cytogenetic study of 12 cases of human herpesvirus 8 associated primary effusion lymphoma in HIV-infected patients.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bleomycin; Chromosome Aberrations; Cidofovir; Cyclophosphamide; Cytosine; Doxorubicin; Drug Therapy, Combination; Etoposide; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Herpesviridae Infections; Herpesvirus 8, Human; Humans; Immunophenotyping; Interferon-alpha; Karyotyping; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large-Cell, Immunoblastic; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Polymerase Chain Reaction; Prednisone; Prognosis; Remission Induction; Survival Analysis; Vincristine; Vindesine; Viral Load | 2001 |
Primary lymphoma of the cervix uteri: a diagnostic challenge. Report of two cases and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, B-Cell; Middle Aged; Neoplasm Staging; Prednisone; Uterine Cervical Neoplasms; Vincristine; Vindesine | 2005 |
Best treatment of aggressive non-Hodgkin's lymphoma: a French perspective.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Doxorubicin; France; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Prednisone; Vindesine | 2005 |
Treatment of Hodgkin lymphoma: the past, present, and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 2008 |
Interventions for previously untreated patients with AIDS-associated non-Hodgkin's lymphoma.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomycin; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Leucovorin; Lymphoma, AIDS-Related; Male; Methotrexate; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Rituximab; Vincristine; Vindesine | 2009 |
Standard therapy of advanced Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Etoposide; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Mechlorethamine; Melphalan; Methylprednisolone; Positron-Emission Tomography; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Salvage Therapy; Transplantation, Autologous; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2009 |
New developments in the management of diffuse large B-cell lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Immunotherapy; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Secondary Prevention; Stem Cell Transplantation; Thalidomide; Vincristine; Vindesine | 2012 |
Membranoproliferative glomerulonephritis in Castleman's disease: a systematic review of the literature and 2 case reports.
Topics: Adult; Castleman Disease; Cyclophosphamide; Drug Therapy, Combination; Female; Glomerulonephritis, Membranoproliferative; Humans; Hyalin; Male; Middle Aged; Prednisone; Vindesine | 2012 |
[Interest of an intensive chemotherapy for intravascular large B cell lymphoma].
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Induction Chemotherapy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rare Diseases; Rituximab; Skin Neoplasms; Vascular Neoplasms; Vindesine | 2013 |
[Standard of care and new drugs for diffuse large B-cell lymphoma].
Topics: Adenine; Animals; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Drug Discovery; Epigenesis, Genetic; Humans; Lenalidomide; Lymphoma, Large B-Cell, Diffuse; Mice; Molecular Targeted Therapy; Piperidines; Prednisolone; Prednisone; Pyrazoles; Pyrimidines; Radiotherapy, Adjuvant; Rituximab; Thalidomide; Vincristine; Vindesine | 2014 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
ACR Appropriateness Criteria® Diffuse Large B-Cell Lymphoma.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Lymphoma, Large B-Cell, Diffuse; Mediastinal Neoplasms; Prednisone; Radiotherapy; Rituximab; Vincristine; Vindesine | 2015 |
Adult T-Cell Leukemia/Lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia-Lymphoma, Adult T-Cell; Prednisone; Vincristine; Vindesine | 2017 |
52 trial(s) available for prednisone and vindesine
| Article | Year |
|---|---|
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1992 |
A study of toxicity and comparative therapeutic efficacy of vindesine-prednisone vs. vincristine-prednisone in children with acute lymphoblastic leukemia in relapse. A Pediatric Oncology Group study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine; Vindesine | 1992 |
Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cyclophosphamide; Daunorubicin; Drug Administration Schedule; Female; France; Humans; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Risk Factors; Vincristine; Vindesine | 1992 |
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine | 1990 |
Treatment of relapsed acute lymphocytic leukemia in adults.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Brain Neoplasms; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Germany, West; Humans; Ifosfamide; Leucovorin; Life Tables; Male; Methotrexate; Middle Aged; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Spinal Cord Neoplasms; Teniposide; Testicular Neoplasms; Vindesine | 1990 |
Sequential versus alternating chemotherapy for high-grade non-Hodgkin's lymphomas: preliminary results of a phase III multicentre trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Randomized Controlled Trials as Topic; Vincristine; Vindesine | 1990 |
[Intermediate results of the German Hodgkin's disease therapy study].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine | 1986 |
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine | 1987 |
Combination chemotherapy including VP-16 for poor prognosis germ cell neoplasms.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Etoposide; Evaluation Studies as Topic; Follow-Up Studies; Humans; Male; Nausea; Neoplasms, Germ Cell and Embryonal; Prednisone; Prognosis; Prospective Studies; Teratoma; Testicular Neoplasms; Vinblastine; Vindesine; Vomiting | 1988 |
Treatment of advanced Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine | 1989 |
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine | 1989 |
Comparison of intermittent or continuous methotrexate plus 6-mercaptopurine in regimens for standard-risk acute lymphoblastic leukemia in childhood (JCCLSG-S811). The Japanese Children's Cancer and Leukemia Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Humans; Leukemia, Lymphoid; Mercaptopurine; Methotrexate; Nervous System Neoplasms; Prednisone; Random Allocation; Remission Induction; Time Factors; Vincristine; Vindesine | 1988 |
[Phase III study of chemotherapy in low-malignancy non-Hodgkin's lymphomas: comparison of vincristine-vindesine combination chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1987 |
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1984 |
Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse.
Topics: Adolescent; Adult; Anemia; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Daunorubicin; Drug Therapy, Combination; Humans; Leukemia, Lymphoid; Leukopenia; Prednisone; Prognosis; Recurrence; Vinblastine; Vindesine | 1983 |
[Phase II study of the treatment of CML blast crisis with vindesine and prednisone].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Pancytopenia; Prednisone; Vinblastine; Vindesine | 1984 |
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine | 1994 |
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Vincristine; Vindesine | 1994 |
VAD-PECC regimen in the treatment of advanced-stage multiple myeloma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multiple Myeloma; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Regression Analysis; Survival Analysis; Treatment Outcome; Vincristine; Vindesine | 1994 |
Randomised comparison of CHOEP versus alternating hCHOP/IVEP for high-grade non-Hodgkin's lymphomas: treatment results and prognostic factor analysis in a multi-centre trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vincristine; Vindesine | 1994 |
Prognostic significance of bcl-2 protein expression in aggressive non-Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Humans; Life Tables; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Prednisone; Prognosis; Proportional Hazards Models; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Risk; Vindesine | 1996 |
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 1995 |
An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Bone Marrow; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mitoxantrone; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 1996 |
Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas. Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cyclophosphamide; Dexamethasone; Doxorubicin; Female; Humans; L-Lactate Dehydrogenase; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Prospective Studies; Skin Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1998 |
[Granisetron (per os) compared with ondansetron (per os) in the prevention of nausea and vomiting induced by mildly emetogenic chemotherapies. Groupe de Recherches en Cancerologie du Nord].
Topics: Adult; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cross-Over Studies; Cyclophosphamide; Doxorubicin; Female; Granisetron; Humans; Male; Methotrexate; Nausea; Ondansetron; Prednisone; Vindesine; Vomiting | 1998 |
Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dexamethasone; Doxorubicin; Drug Administration Schedule; Female; Humans; Immunophenotyping; Leucovorin; Lymphoma; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Vincristine; Vindesine | 2000 |
Quality of life-adjusted survival analysis of high-dose therapy with autologous bone marrow transplantation versus sequential chemotherapy for patients with aggressive lymphoma in first complete remission. Groupe d'Etude les Lymphomes de l'Adulte (GELA).
Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Mitoxantrone; Multivariate Analysis; Prednisone; Quality of Life; Survival Analysis; Transplantation, Autologous; Vindesine | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Primary lymphoma of bone: a prospective study of 28 cases.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Cyclophosphamide; Doxorubicin; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Surveys and Questionnaires; Survival Rate; Treatment Outcome; Vindesine | 2000 |
A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan Clinical Oncology Group Study 9303.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Survival Rate; Time Factors; Vincristine; Vindesine | 2001 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Mitoxantrone; Prednisone; Prospective Studies; Remission Induction; Survival Analysis; Treatment Outcome; Vindesine | 2001 |
Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Survival Rate; Transplantation, Autologous; Treatment Outcome; Vindesine | 2002 |
Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Survival Analysis; Survival Rate; Vincristine; Vindesine | 2003 |
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine; Vindesine | 2004 |
Long-term follow-up of a randomized trial of fludarabine-mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Risk Factors; Vidarabine; Vindesine | 2005 |
ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Survival Analysis; Survival Rate; Treatment Outcome; Vincristine; Vindesine | 2005 |
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2006 |
Autologous stem-cell transplantation as consolidation therapy for diffuse large B-cell lymphoma patients with overexpression of bcl-2 protein. Results of the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trial LNH98-B2.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Genes, bcl-2; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prospective Studies; Stem Cell Transplantation; Survival Rate; Transplantation, Autologous; Vindesine | 2008 |
Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vindesine; Young Adult | 2009 |
Comparison of two high-dose cyclophosphamide, doxorubicin, vincristine, and prednisone derived regimens in patients aged under 60 years with low-intermediate risk aggressive lymphoma: a final analysis of the multicenter LNH93-2 protocol.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Prospective Studies; Survival Rate; Vindesine; Young Adult | 2010 |
SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Fluorodeoxyglucose F18; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prednisone; Prognosis; Prospective Studies; Radiopharmaceuticals; Rituximab; Vincristine; Vindesine | 2011 |
Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Survival Analysis; Transplantation, Autologous; Treatment Outcome; Vindesine; Young Adult | 2011 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 2011 |
Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase 3 trial.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Maximum Tolerated Dose; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Risk Assessment; Rituximab; Severity of Illness Index; Survival Analysis; Treatment Outcome; Vincristine; Vindesine; Young Adult | 2011 |
Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B).
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Rituximab; Treatment Outcome; Vindesine | 2013 |
Young patients with non-germinal center B-cell-like diffuse large B-cell lymphoma benefit from intensified chemotherapy with ACVBP plus rituximab compared with CHOP plus rituximab: analysis of data from the Groupe d'Etudes des Lymphomes de l'Adulte/lympho
Topics: Adult; Algorithms; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Chemokine CCL2; Cyclophosphamide; Disease-Free Survival; DNA-Binding Proteins; Doxorubicin; Female; Humans; Immunohistochemistry; Immunotherapy; Interferon Regulatory Factors; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neprilysin; Prednisolone; Prednisone; Proportional Hazards Models; Proto-Oncogene Proteins c-bcl-6; Proto-Oncogene Proteins c-myc; Rituximab; Treatment Outcome; Vincristine; Vindesine | 2014 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
Long-term outcomes of adults with first-relapsed/refractory systemic anaplastic large-cell lymphoma in the pre-brentuximab vedotin era: A LYSA/SFGM-TC study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Doxorubicin; Female; Humans; Immunoconjugates; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Prednisone; Retrospective Studies; Survival Analysis; Vincristine; Vindesine; Young Adult | 2017 |
Rituximab-PECC induction followed by
Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Autografts; Carmustine; Cyclophosphamide; Disease-Free Survival; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Stem Cell Transplantation; Survival Rate; Vindesine | 2019 |
78 other study(ies) available for prednisone and vindesine
| Article | Year |
|---|---|
Serial changes of the serum macrophage colony-stimulating factor level after cytoreductive chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Daunorubicin; Enzyme-Linked Immunosorbent Assay; Etoposide; Female; Humans; Leukemia, Myeloid, Acute; Leukocyte Count; Leukopenia; Macrophage Colony-Stimulating Factor; Male; Mercaptopurine; Middle Aged; Mitoxantrone; Predictive Value of Tests; Prednisone; Remission Induction; Vindesine | 1992 |
[Combination chemotherapy with mitoxantrone, etoposide, vindesine and prednisolone for relapsed or refractory malignant lymphoma: presence of cross-resistance to CHOP therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisolone; Prednisone; Recurrence; Vincristine; Vindesine | 1992 |
Treatment of relapsed or refractory adult acute lymphocytic leukemia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Vindesine | 1992 |
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1987 |
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].
Topics: Antineoplastic Combined Chemotherapy Protocols; Dermatitis, Exfoliative; Drug Eruptions; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Vincristine; Vindesine | 1989 |
Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Prednisone; Prognosis; Sarcoma, Ewing; Vincristine; Vindesine | 1988 |
Methylprednisolone, etoposide, vindesine, and chlorambucil (PEEC) alone or alternating with CHOP as initial or salvage therapy for non-Hodgkin's lymphoma.
Topics: Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methylprednisolone; Middle Aged; Nausea; Prednisone; Prognosis; Remission Induction; Vincristine; Vindesine | 1988 |
Interstitial lung disease associated with vindesine and radiation therapy for carcinoma of the lung.
Topics: Aged; Carcinoma, Squamous Cell; Combined Modality Therapy; Female; Humans; Lung Neoplasms; Prednisone; Pulmonary Fibrosis; Radiation Injuries; Vindesine | 1986 |
Vindesine-prednisone in the treatment of blast crisis of chronic myeloid leukemia.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Drug Administration Schedule; Female; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged; Prednisone; Time Factors; Vinblastine; Vindesine | 1985 |
Treatment of chronic myeloid leukemia blast crisis with vindesine and prednisone.
Topics: Adult; Aged; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Leukocyte Count; Male; Middle Aged; Paresthesia; Platelet Count; Prednisone; Prognosis; Vinblastine; Vindesine | 1985 |
Vindesine in refractory multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Prognosis; Vincristine; Vindesine | 1986 |
Vindesine in plasma cell tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Evaluation; Drug Resistance; Female; Humans; Male; Middle Aged; Multiple Myeloma; Plasmacytoma; Prednisone; Vindesine | 1985 |
[Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Male; Middle Aged; Prednisone; Vinblastine; Vindesine | 1981 |
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1983 |
Acute allergic reaction due to vincristine sulfate. A case report.
Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Hypersensitivity; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine | 1984 |
Combination of vindesine and prednisone in malignant lymphoma and acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vinblastine; Vindesine | 1983 |
[Lymphoid blast crisis in chronic myelogenous leukemia].
Topics: Aged; Alkaline Phosphatase; Bone Marrow Examination; Busulfan; Chromosomes, Human, 21-22 and Y; Female; Humans; L-Lactate Dehydrogenase; Leukemia, Lymphoid; Leukemia, Myeloid; Prednisone; Vinblastine; Vincristine; Vindesine | 1984 |
Chemotherapy for acute leukemia during pregnancy. Five case reports.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Doxorubicin; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Vinblastine; Vincristine; Vindesine | 1984 |
Progress report on vindesine treatment of melphalan-resistant multiple myeloma.
Topics: Antineoplastic Agents; Drug Resistance; Drug Therapy, Combination; Humans; Melphalan; Multiple Myeloma; Prednisone; Vinblastine; Vindesine | 1983 |
Cyclophosphamide, doxorubicin, prednisone and vindesine combination chemotherapy in melphalan-resistant multiple myeloma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Resistance; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Vinblastine; Vindesine | 1984 |
Plasma spermidine concentrations as early indication of response to therapy in human myeloma.
Topics: Antineoplastic Agents; Humans; Multiple Myeloma; Prednisone; Prognosis; Spermidine; Time Factors; Vinblastine; Vindesine | 1983 |
Prednisone pulse therapy for refractory myeloma.
Topics: Bone Marrow; Doxorubicin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Plasma Cells; Prednisone; Vinblastine; Vincristine; Vindesine | 1983 |
Vindesine and prednisone for remission induction in children with acute lymphocytic leukemia.
Topics: Adolescent; Child; Child, Preschool; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Humans; Leukemia, Lymphoid; Male; Prednisone; Vinblastine; Vindesine | 1981 |
[Results of 2 protocols in the treatment of acute lymphoid leukemia in children, according to prognostic factors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; BCG Vaccine; Child; Combined Modality Therapy; Doxorubicin; Humans; Leukemia, Lymphoid; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Prednisone; Prognosis; Vincristine; Vindesine | 1982 |
Vindesine therapy in melphalan-resistant multiple myeloma.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Drug Resistance; Drug Therapy, Combination; Female; Humans; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloma Proteins; Prednisone; Vinblastine; Vindesine | 1981 |
[Lung fibrosis after bleomycin therapy].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans; Lung Neoplasms; Male; Mechlorethamine; Prednisone; Procarbazine; Pulmonary Fibrosis; Vincristine; Vindesine | 1994 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1993 |
Clinical importance of P-glycoprotein-related resistance in leukemia and myelodysplastic syndromes--first experience with their reversal.
Topics: Adult; Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blast Crisis; Bone Marrow Cells; Carrier Proteins; Drug Resistance; Humans; Immunohistochemistry; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Membrane Glycoproteins; Middle Aged; Molecular Sequence Data; Monocytes; Myelodysplastic Syndromes; Neoplasm Proteins; Polymerase Chain Reaction; Prednisone; Vindesine | 1994 |
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1993 |
Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Humans; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Prednisone; Prognosis; Recurrence; Remission Induction; Retrospective Studies; Risk Factors; Survival Rate; Vindesine | 1996 |
Peripheral-T-cell lymphoma with hemophagocytic histiocytosis localised to the bone marrow associated with inappropriate secretion of antidiuretic hormone.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Cyclophosphamide; Cytarabine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Histiocytosis, Non-Langerhans-Cell; Humans; Ifosfamide; Inappropriate ADH Syndrome; Lymphoma, T-Cell, Peripheral; Methotrexate; Mitoguazone; Prednisone; Teniposide; Verapamil; Vincristine; Vindesine | 1995 |
[Treatment of aggressive non Hodgkin's lymphoma: the experience of a general hospital].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Female; Hospitals, General; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Survival Analysis; Vincristine; Vindesine | 1996 |
[Diagnosis and therapeutic management of gastric lymphomas].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Gastrectomy; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitomycin; Prednisone; Radioisotope Teletherapy; Remission Induction; Retrospective Studies; Spain; Stomach Neoplasms; Treatment Outcome; Vincristine; Vindesine | 1996 |
Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome.
Topics: Adult; Aged; Alleles; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cohort Studies; Cyclophosphamide; Disease-Free Survival; DNA, Neoplasm; Doxorubicin; Female; Gene Expression Regulation, Neoplastic; Genotype; Haplotypes; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Proteins; Polymerase Chain Reaction; Polymorphism, Genetic; Polymorphism, Restriction Fragment Length; Prednisone; Proportional Hazards Models; Survival Analysis; Transcription, Genetic; Treatment Outcome; Tumor Necrosis Factor-alpha; Vincristine; Vindesine | 1998 |
Hepatosplenic alphabeta T-cell lymphoma: an unusual case with clinical, histologic, and cytogenetic features of gammadelta hepatosplenic T-cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosomes, Human, Pair 7; Cyclophosphamide; DNA, Neoplasm; Doxorubicin; Fatal Outcome; Humans; Immunophenotyping; In Situ Hybridization, Fluorescence; Isochromosomes; Liver Neoplasms; Lymphoma, T-Cell; Male; Prednisone; Receptors, Antigen, T-Cell, alpha-beta; Receptors, Antigen, T-Cell, gamma-delta; Splenic Neoplasms; T-Lymphocytes; Vindesine | 2000 |
Intensive chemotherapy (LNHIV-91 regimen) and G-CSF for HIV associated non-Hodgkin's lymphoma.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD4 Lymphocyte Count; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Evaluation; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Hospitalization; Humans; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Recurrence; Survival Rate; Treatment Outcome; Vindesine | 2000 |
Pathologic and clinical features of 77 Hodgkin's lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Female; Hodgkin Disease; Humans; Immunoenzyme Techniques; Immunophenotyping; Lymphoma, Large-Cell, Anaplastic; Male; Middle Aged; Neoplasm Proteins; Prednisone; Survival Rate; Treatment Outcome; Vindesine | 2001 |
Tandem autotransplant as first-line consolidative treatment in poor-risk aggressive lymphoma: a pilot study of 36 patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Hematopoietic Stem Cell Transplantation; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Palliative Care; Pilot Projects; Prednisone; Prognosis; Risk Factors; Survival Rate; T-Lymphocytes; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Vindesine | 2001 |
[Multinodular hepatopathy].
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Follow-Up Studies; Humans; Liver; Liver Neoplasms; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Prognosis; Sex Factors; Time Factors; Ultrasonography; Vindesine | 2002 |
Induction of long-term remission of a relapsed childhood B-acute lymphoblastic leukemia with rituximab chimeric anti-CD20 monoclonal antibody and autologous stem cell transplantation.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Burkitt Lymphoma; Child; Combined Modality Therapy; Cytarabine; Dexamethasone; Etoposide; Humans; Immunotherapy; Leukemic Infiltration; Male; Meninges; Methotrexate; Peripheral Blood Stem Cell Transplantation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Recurrence; Remission Induction; Rituximab; Salvage Therapy; Testis; Topotecan; Transplantation, Autologous; Vindesine | 2003 |
Second cancers and late toxicities after treatment of aggressive non-Hodgkin lymphoma with the ACVBP regimen: a GELA cohort study on 2837 patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cohort Studies; Cyclophosphamide; Doxorubicin; Female; Humans; Incidence; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasms, Second Primary; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Retrospective Studies; Risk Factors; Vindesine | 2004 |
Co-existent primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Interprofessional Relations; Lymphoma, Large-Cell, Anaplastic; Lymphomatoid Papulosis; Neoplasms, Multiple Primary; Patient Care Team; Polymerase Chain Reaction; Prednisolone; Prednisone; Treatment Outcome; Vincristine; Vindesine | 2003 |
[Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Infant; Leucovorin; Lymphoma, B-Cell; Male; Methotrexate; Neoplasm Staging; Prednisone; Survival Rate; Vincristine; Vindesine | 2004 |
Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Neoplasm Staging; Prednisone; Prognosis; Vincristine; Vindesine | 2005 |
Severe interstitial pneumonitis following rituximab and bleomycin-containing combination chemotherapy.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lung Diseases, Interstitial; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vindesine | 2005 |
Treatment of localized lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Survival Analysis; Vincristine; Vindesine | 2005 |
Treatment of localized lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Recurrence; Vincristine; Vindesine | 2005 |
Thalidomide for the treatment of leptomeningeal multiple myeloma.
Topics: Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Etoposide; Fatal Outcome; Female; Humans; Immunoglobulin G; Melphalan; Meningeal Neoplasms; Middle Aged; Multiple Myeloma; Nitrosourea Compounds; Prednisolone; Prednisone; Thalidomide; Vindesine | 2006 |
[Plasmacytoma with multiple hypervascular lesions revealed by angiography in a patient with multiple myeloma].
Topics: Aged; Angiography; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Drug Administration Schedule; Female; Humans; Melphalan; Multiple Myeloma; Neovascularization, Pathologic; Nitrosourea Compounds; Plasmacytoma; Prednisolone; Prednisone; Tomography, X-Ray Computed; Vindesine | 2006 |
Long-term survival in post-transplant lymphoproliferative disorders with a dose-adjusted ACVBP regimen.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Female; Humans; Lymphoproliferative Disorders; Male; Middle Aged; Organ Transplantation; Postoperative Complications; Prednisone; Survival Rate; Treatment Outcome; Vincristine; Vindesine | 2006 |
Refractory multiple myeloma treated with homoharringtonine: report of two cases.
Topics: Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Carmustine; Cyclophosphamide; Dexamethasone; Doxorubicin; Harringtonines; Homoharringtonine; Humans; Male; Melphalan; Multiple Myeloma; Oxides; Prednisone; Remission Induction; Salvage Therapy; Thalidomide; Vincristine; Vindesine | 2007 |
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Patient Selection; Prednisone; Retrospective Studies; Survival Analysis; Time Factors; Vindesine | 2008 |
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult | 2009 |
Changes in serum tryptophan catabolism as an indicator of disease activity in adult T-cell leukemia/lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Drug Monitoring; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Kynurenine; Leukemia-Lymphoma, Adult T-Cell; Metabolic Networks and Pathways; Neoplasm Proteins; Neoplastic Cells, Circulating; Neutropenia; Nitrosourea Compounds; Prednisone; Receptors, Interleukin-2; Tryptophan; Tryptophan Oxygenase; Vincristine; Vindesine | 2009 |
Post transplant anaplastic large T-cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Creatinine; Cyclophosphamide; Cyclosporine; Doxorubicin; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphoma, Large-Cell, Anaplastic; Male; Mycophenolic Acid; Postoperative Complications; Prednisone; Vindesine | 2009 |
Pharmacokinetics of rituximab in patients with CD20 positive B-cell malignancies.
Topics: Adult; Aged; Antibodies; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Carmustine; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Rituximab; Treatment Outcome; Vidarabine; Vincristine; Vindesine | 2010 |
Intensified chemotherapy for diffuse large B-cell lymphomas.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Rituximab; Vindesine | 2011 |
Impact of rituximab on stem cell mobilization following ACVBP regimen in poor-risk patients with diffuse large B-cell lymphoma: results from a large cohort of patients.
Topics: Adolescent; Adult; Antibodies, Monoclonal, Murine-Derived; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Hematopoietic Stem Cell Mobilization; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Rituximab; Vindesine; Young Adult | 2013 |
A retrospective analysis of periodontitis during bevacizumab treatment in metastatic colorectal cancer patients.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Colorectal Neoplasms; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Female; Fluorouracil; Humans; Leucovorin; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Periodontitis; Prednisone; Retrospective Studies; Treatment Outcome; Vindesine | 2013 |
Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin.
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Bicarbonates; Bleomycin; Ciprofloxacin; Crystallization; Cyclophosphamide; Cytarabine; Diarrhea; Doxorubicin; Drug Eruptions; Drug Interactions; Etoposide; Female; Fluid Therapy; Fungemia; Humans; Hydrogen-Ion Concentration; Ifosfamide; Lymphoma, B-Cell; Mediastinal Neoplasms; Metabolic Clearance Rate; Methotrexate; Mucositis; Pancytopenia; Prednisone; Solubility; Urine; Vindesine | 2013 |
Fifteenth biannual report of the Cochrane Haematological Malignancies Group--focus on non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Bleomycin; Cyclophosphamide; Dasatinib; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lymphoma, Non-Hodgkin; Middle Aged; Multicenter Studies as Topic; Multiple Myeloma; Neoplasm Staging; Piperazines; Platelet Transfusion; Prednisone; Primary Prevention; Procarbazine; Pyrimidines; Randomized Controlled Trials as Topic; Rituximab; Stem Cell Transplantation; Survival Analysis; Thiazoles; Thrombocytopenia; Transplantation, Autologous; Treatment Outcome; Vincristine; Vindesine | 2013 |
Loss of CCR4 antigen expression after mogamulizumab therapy in a case of adult T-cell leukaemia-lymphoma.
Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Clone Cells; Cyclophosphamide; Down-Regulation; Doxorubicin; Etoposide; Fatal Outcome; Female; Gene Expression Regulation, Neoplastic; Humans; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Neoplasm Proteins; Nitrosourea Compounds; Prednisone; Receptors, CCR4; Vincristine; Vindesine | 2013 |
[Localized primary bone lymphoma: about four cases].
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Clavicle; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Femoral Neoplasms; Fractures, Spontaneous; Humans; Humeral Fractures; Humerus; Lymphoma, Non-Hodgkin; Male; Mandibular Neoplasms; Middle Aged; Osteolysis; Prednisone; Prognosis; Radioisotope Teletherapy; Remission Induction; Rituximab; Vincristine; Vindesine | 2014 |
[Clinical characteristics and efficacy analysis for patients over 55 years of age with acute lymphoblastic leukemia].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Consolidation Chemotherapy; Cyclophosphamide; Daunorubicin; Dexamethasone; Disease-Free Survival; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Induction Chemotherapy; Maintenance Chemotherapy; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prednisone; Remission Induction; Retrospective Studies; Survival Rate; Vincristine; Vindesine | 2013 |
Comparison of vindesine and prednisone and cyclophosphamide, etoposide, vindesine, and prednisone as first-line treatment for adult Langerhans cell histiocytosis: A single-center retrospective study.
Topics: Adolescent; Adult; Aged; Cyclophosphamide; Drug Therapy, Combination; Etoposide; Female; Histiocytosis, Langerhans-Cell; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prednisone; Recurrence; Retrospective Studies; Treatment Outcome; Vindesine; Young Adult | 2016 |
Spontaneous regression of adult T cell leukemia/lymphoma following development of immune thrombocytopenia.
Topics: Adrenal Cortex Hormones; Allografts; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrazines; Leukemia-Lymphoma, Adult T-Cell; Middle Aged; Nitrosourea Compounds; Prednisolone; Prednisone; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Remission, Spontaneous; Vincristine; Vindesine | 2016 |
Effects of first-line chemotherapy on natural killer cells in adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Case-Control Studies; Cyclophosphamide; Doxorubicin; Etoposide; Female; Flow Cytometry; Humans; Killer Cells, Natural; Leukemia-Lymphoma, Adult T-Cell; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Vincristine; Vindesine | 2016 |
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Topics: Cyclophosphamide; Doxorubicin; Drug Stability; Epirubicin; Etoposide; Humans; Infusion Pumps; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine | 2019 |
Vincristine Shortage: What Other Options We Have?
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bortezomib; Cyclophosphamide; Doxorubicin; Drug Substitution; Humans; Leukemia; Liposomes; Lymphoma; Prednisone; Vinblastine; Vincristine; Vindesine | 2020 |
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Doxorubicin; Female; Health Care Surveys; Hematopoietic Stem Cell Transplantation; Hospitals; Humans; Japan; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Nitrosourea Compounds; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine; Vindesine | 2020 |
Beclin1‑armed oncolytic Vaccinia virus enhances the therapeutic efficacy of R‑CHOP against lymphoma in vitro and in vivo.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Autophagic Cell Death; Beclin-1; Biopsy; Cell Line, Tumor; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Genetic Engineering; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Middle Aged; Oncolytic Virotherapy; Oncolytic Viruses; Prednisone; Rituximab; Tumor Escape; Vaccinia virus; Vincristine; Vindesine; Xenograft Model Antitumor Assays | 2021 |
Safety and Efficacy of Replacing Vindesine with Vincristine in R-ACVBP Regimen for the Treatment of Large B Cell Lymphomas.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Retrospective Studies; Vincristine; Vindesine; Young Adult | 2021 |
Peripheral blood CD45RO+T cells is a predictor of the effectiveness of neoadjuvant chemoradiotherapy in locally advanced rectal cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Chemoradiotherapy, Adjuvant; Colonoscopy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Flow Cytometry; Follow-Up Studies; Humans; Leukocyte Common Antigens; Lymphocyte Count; Male; Middle Aged; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasm Staging; Oxaliplatin; Prednisone; Preoperative Period; Proctectomy; Prognosis; Radiotherapy, Intensity-Modulated; Rectal Neoplasms; Rectum; Retrospective Studies; Survival Rate; T-Lymphocyte Subsets; Vindesine | 2021 |
Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; CD28 Antigens; Cyclophosphamide; DNA Copy Number Variations; Doxorubicin; Etoposide; Female; Genes, p53; Hematopoietic Stem Cell Transplantation; Humans; INDEL Mutation; Kaplan-Meier Estimate; Lenalidomide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Mutation; Nitrosourea Compounds; Polymorphism, Single Nucleotide; Prednisolone; Prednisone; Prognosis; Receptors, CCR4; Vincristine; Vindesine | 2021 |
Long-time follow-up of patients with untreated peripheral T cell lymphoma following chidamide combined with cyclophosphamide, epirubicin, vindesine, prednisone, and etoposide therapy: a single-center propensity score-matching study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Propensity Score; Retrospective Studies; Vincristine; Vindesine | 2023 |
Acute and Persistent Remission of Aggressive Natural Killer Cell Leukemia in an Older Patient Induced by Chidamide Combined with Cyclophosphamide, Vindesine, Prednisone, and Etoposide Therapy
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Humans; Leukemia, Large Granular Lymphocytic; Prednisone; Vincristine; Vindesine | 2023 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |